CN105641404A - Traditional Chinese medicine composition for treating roseola - Google Patents
Traditional Chinese medicine composition for treating roseola Download PDFInfo
- Publication number
- CN105641404A CN105641404A CN201610100666.3A CN201610100666A CN105641404A CN 105641404 A CN105641404 A CN 105641404A CN 201610100666 A CN201610100666 A CN 201610100666A CN 105641404 A CN105641404 A CN 105641404A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 47
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 201000005866 Exanthema Subitum Diseases 0.000 title abstract description 8
- 208000036485 Roseola Diseases 0.000 title abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 240000008564 Boehmeria nivea Species 0.000 claims abstract description 11
- 241000628997 Flos Species 0.000 claims description 20
- 239000010231 banlangen Substances 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 30
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 21
- 238000001816 cooling Methods 0.000 abstract description 9
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 244000052769 pathogen Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 235000008216 herbs Nutrition 0.000 abstract 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 241000906579 Actaea cimicifuga Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 240000005250 Chrysanthemum indicum Species 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 244000111489 Gardenia augusta Species 0.000 abstract 1
- 235000018958 Gardenia augusta Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000005206 Hibiscus Nutrition 0.000 abstract 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 abstract 1
- 244000048199 Hibiscus mutabilis Species 0.000 abstract 1
- 235000003973 Hibiscus mutabilis Nutrition 0.000 abstract 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 244000261422 Lysimachia clethroides Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 235000008081 Rheum officinale Nutrition 0.000 abstract 1
- 240000001745 Rheum palmatum Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 244000145469 Vernonia anthelmintica Species 0.000 abstract 1
- 235000013018 Vernonia anthelmintica Nutrition 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 235000005301 cimicifuga racemosa Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 239000003440 toxic substance Substances 0.000 description 16
- 231100000614 poison Toxicity 0.000 description 14
- 230000001737 promoting effect Effects 0.000 description 10
- 230000017531 blood circulation Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 229940124623 antihistamine drug Drugs 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 206010013663 drug dependence Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 229960003291 chlorphenamine Drugs 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 description 1
- JJCFRYNCJDLXIK-UHFFFAOYSA-N cyproheptadine Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2C=CC2=CC=CC=C21 JJCFRYNCJDLXIK-UHFFFAOYSA-N 0.000 description 1
- 229960001140 cyproheptadine Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses traditional Chinese medicine composition for treating roseola. The traditional Chinese medicine composition comprises traditional Chinese medicine raw materials in parts by weight as follows: 10-30 parts of honeysuckle, 10-20 parts of lithospermum erythrorhizon, 5-15 parts of belvedere fruits, 10-20 parts of tribulus terrestris, 10-20 parts of chrysanthemums, 5-15 parts of dwarf lilyturf tuber, 10-20 parts of indigowoad roots, 10-20 parts of indigowoad leaves, 5-15 parts of cicada slough, 10-20 parts of herba ecliptae, 10-20 parts of danshen roots, 10-20 parts of Chinese rhubarb, 5-15 parts of weeping forsythiae capsule, 10-20 parts of cottonrose hibiscus, 10-20 parts of figwort roots, 5-15 parts of largetrifoliolious bugbane rhizome, 10-20 parts of clethra loosestrife herbs, 10-20 parts of rhizoma chuanxiong, 5-15 parts of saffron, 10-20 parts of herbs of halfspreading ironweed, 10-20 parts of cape jasmine fruits, 10-20 parts of ramie leaves and 5-15 parts of liquorice. The traditional Chinese medicine composition has the functions of cooling blood, dispelling wind, tonifying qi, expulsing pathogen, clearing away heat and toxic materials and moistening and nourishing the skin, the curative effect on roseola is remarkable, and the action is reliable.
Description
Technical field
The present invention relates to the medicinal preparation not determining structure of a kind of traditional herbal medicines, especially one treats roseolous Chinese medicine composition.
Background technology
Roseola is also roseola infantum, is burnt rash, caused by virus, it it is infant a kind of common eruptive contagious diseases in period, it is a kind of cherry circular macule, diameter 2-3mm, is mainly dispersed in trunk, cervical region and upper limb, perilesional vasodilation formed, fading of pressure, has reproduction when unclamping. Generally continue 6-8 all and spontaneous recovery, but also have prolonged situation about not healing. At present, clinically frequently with method have: the antihistamine drugs such as oral chlorphenamine, Cyproheptadine, teldane and loratadine, it is also possible to vitamin C; External glucocorticosteroid Hormonal ointment. Though said medicine has certain effect, but easily produces drug dependence, so recurrent exerbation.
The traditional Chinese medical science is thought, roseola is to have heat in blood because of internal, feels ailment said due to cold or exposure again, and pyretic toxicity condenses, strongly fragrant in skin, inaccessible space between skin and muscles and fall ill; Or exposure to wind when sweating, make clothing soaked with sweat and become soaked with sweat caused by skin.
According to theory of Chinese medical science, for roseolous pathogeny, with cooling blood, expelling wind, heat-clearing and toxic substances removing, moisten foster skin for the rule for the treatment of, carry out dialectical composition of prescription, to reach the purpose for the treatment of both the principal and secondary aspects of a disease.
Summary of the invention
In order to overcome existing employing antihistamine drug and Hormonal ointment treatment roseola to exist, drug dependence is strong, drug withdrawal easily deficiency repeatedly, the present invention provide a kind of prepare conveniently, medicine source is wide, cost is low, evident in efficacy, reliable effect, the roseolous Chinese medicine composition for the treatment of that has no side effect.
The technical solution adopted for the present invention to solve the technical problems is: one treats roseolous Chinese medicine composition, it is characterized in that: its raw material of Chinese medicine and weight be: Flos Lonicerae 10-30 part, Radix Arnebiae (Radix Lithospermi) 10-20 part, Fructus Kochiae 5-15 part, Fructus Atriplicis Sibiricae 10-20 part, Flos Chrysanthemi 10-20 part, Radix Ophiopogonis 5-15 part, Radix Isatidis 10-20 part, Folium Isatidis 10-20 part, Periostracum Cicadae 5-15 part, Herba Ecliptae 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Radix Et Rhizoma Rhei 10-20 part, Fructus Forsythiae 5-15 part, Hibisci Mutabilis 10-20 part, Radix Scrophulariae 10-20 part, Rhizoma Cimicifugae 5-15 part, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 10-20 part, Rhizoma Chuanxiong 10-20 part, Stigma Croci 5-15 part, Herba Vernoniae Patulae 10-20 part, Fructus Gardeniae 10-20 part, ramie leaf 10-20 part, Radix Glycyrrhizae 5-15 part.
The preferred technical solution of the present invention is: one treats roseolous Chinese medicine composition, it is characterised in that: its raw material of Chinese medicine and weight be: Flos Lonicerae 20 parts, Radix Arnebiae (Radix Lithospermi) 15 parts, the Fructus Kochiae 10 parts, Fructus Atriplicis Sibiricae 15 parts, Flos Chrysanthemi 15 parts, Radix Ophiopogonis 10 parts, Radix Isatidis 15 parts, Folium Isatidis 15 parts, Periostracum Cicadae 10 parts, Herba Ecliptae 15 parts, Radix Salviae Miltiorrhizae 15 parts, Radix Et Rhizoma Rhei 15 parts, Fructus Forsythiae 10 parts, Hibisci Mutabilis 15 parts, Radix Scrophulariae 15 parts, Rhizoma Cimicifugae 10 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15 parts, Rhizoma Chuanxiong 15 parts, Stigma Croci 10 parts, Herba Vernoniae Patulae 15 parts, Fructus Gardeniae 15 parts, ramie leaf 15 parts, 10 parts of Radix Glycyrrhizae.
Chinese medicine composition of the present invention is under Traditional Chinese medical theory and clinical experience instruct, selected medicament composing prescription. In Chinese medicine composition of the present invention: Flos Lonicerae has effect of heat-clearing and toxic substances removing, wind-heat dissipating; Radix Arnebiae (Radix Lithospermi) has effect of clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling, removing toxic substances rash; The Fructus Kochiae has effect of diuresis, clearing away damp-heat; Fructus Atriplicis Sibiricae has effect of suppressing the hyperactive liver resolving depression, dispelling pathogenic wind for improving eyesight; Flos Chrysanthemi has effect of dispelling wind and heat pathogens, suppressing the hyperactive liver improving eyesight, heat-clearing and toxic substances removing; There is Radix Ophiopogonis YIN nourishing and the production of body fluid promoting, effect that lung moistening clears away heart-fire; Radix Isatidis has effect of heat-clearing and toxic substances removing, removing heat from blood detumescence, sore-throat relieving; Folium Isatidis has effect of heat-clearing and toxic substances removing, cooling blood for hemostasis; Periostracum Cicadae has scattered wind heat extraction, lung qi dispersing determines effect of convulsion; Herba Ecliptae has effect of liver-nourishing kidney-boosting, cooling blood for hemostasis; Radix Salviae Miltiorrhizae has effect of promoting blood flow to regulate menstruation, blood stasis dispelling eliminating carbuncle, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind; Radix Et Rhizoma Rhei has effect of pathogenic fire purging removing food stagnancy, heat-clearing and toxic substances removing, cooling blood for hemostasis, blood stasis dispelling cough-relieving; Fructus Forsythiae has effect of heat-clearing and toxic substances removing, mass dissipating and swelling eliminating; Hibisci Mutabilis has effect of clearing away heat and cooling blood, removing toxic substances and promoting subsidence of swelling, toxin expelling; Radix Scrophulariae has effect of removing heat from blood YIN nourishing, eliminating fire and detoxication; Rhizoma Cimicifugae has the effect delivering rash, heat-clearing and toxic substances removing, liter act yang-energy; Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) has effect of promoting blood flow to regulate menstruation, removing toxic substances and promoting subsidence of swelling; Rhizoma Chuanxiong has effect of blood circulation promoting and blood stasis dispelling, activating QI to alleviate the depression, wind-expelling pain-stopping; Stigma Croci has effect of blood circulation promoting and blood stasis dispelling, removing pathogenic heat from blood and toxic substance from the body, resolving stagnation for tranquilization; Herba Vernoniae Patulae has effect of fresh breeze heat clearing away, eliminating damp, detoxifying, dissipating blood stasis for subsidence of swelling; Fructus Gardeniae has effect of pathogenic fire purging relieving restlessness, clearing away heat and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body; Ramie leaf has effect of cooling blood for hemostasis, removing toxic substances and promoting subsidence of swelling; Radix Glycyrrhizae has effect of invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, coordinating the actions of various ingredients in a prescription. Drug component in the present composition, through dialectical compatibility, complements each other using, and has synergism, plays cooling blood, expelling wind altogether, QI invigorating is got rid of evils, heat-clearing and toxic substances removing, moisten effect of foster skin, and roseola reaches the purpose for the treatment of both the principal and secondary aspects of a disease.
The component of the present composition all adopts natural raw material of Chinese medicine, and preparation is easy, medicine source is wide, cost is low for it. It follows the prescriptions principle of the traditional Chinese medical science, and various component drug adopt the use that is decocted in water for oral dose. Verifying by clinic application, it is evident in efficacy, reliable effect, mild in medicine property and, toxic and side effects does not occur, total effective rate 91.4%, cure rate reaches 65.7%.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
One treats roseolous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Flos Lonicerae 20g, Radix Arnebiae (Radix Lithospermi) 15g, Fructus Kochiae 10g, Fructus Atriplicis Sibiricae 15g, Flos Chrysanthemi 15g, Radix Ophiopogonis 10g, Radix Isatidis 15g, Folium Isatidis 15g, Periostracum Cicadae 10g, Herba Ecliptae 15g, Radix Salviae Miltiorrhizae 15g, Radix Et Rhizoma Rhei 15g, Fructus Forsythiae 10g, Hibisci Mutabilis 15g, Radix Scrophulariae 15g, Rhizoma Cimicifugae 10g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15g, Rhizoma Chuanxiong 15g, Stigma Croci 10g, Herba Vernoniae Patulae 15g, Fructus Gardeniae 15g, ramie leaf 15g, Radix Glycyrrhizae 10g.
Embodiment 2
One treats roseolous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Flos Lonicerae 30g, Radix Arnebiae (Radix Lithospermi) 10g, Fructus Kochiae 15g, Fructus Atriplicis Sibiricae 10g, Flos Chrysanthemi 20g, Radix Ophiopogonis 5g, Radix Isatidis 20g, Folium Isatidis 10g, Periostracum Cicadae 15g, Herba Ecliptae 10g, Radix Salviae Miltiorrhizae 20g, Radix Et Rhizoma Rhei 10g, Fructus Forsythiae 15g, Hibisci Mutabilis 10g, Radix Scrophulariae 20g, Rhizoma Cimicifugae 5g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 20g, Rhizoma Chuanxiong 10g, Stigma Croci 15g, Herba Vernoniae Patulae 10g, Fructus Gardeniae 20g, ramie leaf 10g, Radix Glycyrrhizae 15g.
Embodiment 3
One treats roseolous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Flos Lonicerae 10g, Radix Arnebiae (Radix Lithospermi) 20g, Fructus Kochiae 5g, Fructus Atriplicis Sibiricae 20g, Flos Chrysanthemi 10g, Radix Ophiopogonis 15g, Radix Isatidis 10g, Folium Isatidis 20g, Periostracum Cicadae 5g, Herba Ecliptae 20g, Radix Salviae Miltiorrhizae 10g, Radix Et Rhizoma Rhei 20g, Fructus Forsythiae 5g, Hibisci Mutabilis 20g, Radix Scrophulariae 10g, Rhizoma Cimicifugae 15g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 10g, Rhizoma Chuanxiong 20g, Stigma Croci 5g, Herba Vernoniae Patulae 20g, Fructus Gardeniae 10g, ramie leaf 20g, Radix Glycyrrhizae 5g.
Embodiment 4
One treats roseolous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Flos Lonicerae 23g, Radix Arnebiae (Radix Lithospermi) 12g, Fructus Kochiae 13g, Fructus Atriplicis Sibiricae 12g, Flos Chrysanthemi 18g, Radix Ophiopogonis 8g, Radix Isatidis 18g, Folium Isatidis 13g, Periostracum Cicadae 13g, Herba Ecliptae 12g, Radix Salviae Miltiorrhizae 18g, Radix Et Rhizoma Rhei 13g, Fructus Forsythiae 13g, Hibisci Mutabilis 12g, Radix Scrophulariae 18g, Rhizoma Cimicifugae 8g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 18g, Rhizoma Chuanxiong 13g, Stigma Croci 12g, Herba Vernoniae Patulae 13g, Fructus Gardeniae 18g, ramie leaf 12g, Radix Glycyrrhizae 13g.
Embodiment 5
One treats roseolous Chinese medicine composition, and its raw material of Chinese medicine and weight proportion be: Flos Lonicerae 18g, Radix Arnebiae (Radix Lithospermi) 17g, Fructus Kochiae 8g, Fructus Atriplicis Sibiricae 17g, Flos Chrysanthemi 13g, Radix Ophiopogonis 12g, Radix Isatidis 13g, Folium Isatidis 18g, Periostracum Cicadae 8g, Herba Ecliptae 18g, Radix Salviae Miltiorrhizae 13g, Radix Et Rhizoma Rhei 18g, Fructus Forsythiae 8g, Hibisci Mutabilis 18g, Radix Scrophulariae 13g, Rhizoma Cimicifugae 12g, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 13g, Rhizoma Chuanxiong 18g, Stigma Croci 8g, Herba Vernoniae Patulae 18g, Fructus Gardeniae 13g, ramie leaf 18g, Radix Glycyrrhizae 8g.
Chinese medicine composition in embodiment of the present invention decocting method routinely produces medicament. Concrete grammar is as follows: put in container by the raw material of Chinese medicine of prescription, adds cold water and covers powder, soak 15��20 minutes, adds water and do not have powder about 5 centimetres, carries out first time decoction, adopts intense fire to decoct before at a simmer, with slow fire boiling 20��30 minutes after boiling; Second time decocts, and adds water and did not have powder about 4 centimetres, and water decocts 15��20 minutes after boiling. Twice decoction is removed slag extracting juice, merges.
The present invention treats roseolous Chinese medicine composition with the one given by embodiment 1, does clinical efficacy and is summarized as follows:
One, general data: Chinese medicine composition of the present invention is applied to clinical observation case 70 example, wherein, male 32 examples, female 38 example, 3��30 years old age.
Two, diagnostic criteria:
1, volume is oval or circular rose-colored macule, and major axis is consistent with dermatoglyph trend, and surface is covered with eckband shape squama;
2, it is dispersed in and is distributed in trunk and extremity near-end;
3, there is scratchiness in various degree;
4, being more common in season in spring and autumn, patient mostly is infant;
5, some patients companion grade fever, headache, pharyngalgia, general malaise, cervical region or oxter superficial lymph tie the symptoms such as enlargement.
Three, usage and dosage: during clinical practice, one day potion, twice extracting juice of decocting is about 200ml, and point morning, late twice half an hour ante cibum warm and take, three days courses for the treatment of. Take medicine period avoid eating anything raw or cold, pungent thing.
Four, criterion of therapeutical effect:
1, cure: curing completely and not recurring does not have complication;
2, take a turn for the better: major part is cured and fraction recurrence;
3, do not heal: do not cure and diffusion.
Five, therapeutic effect: in this clinical observation case, take medicine 4-10 the course for the treatment of, cure 46 examples, take a turn for the better 18 examples, and do not heal 6 examples. Toxic and side effects is there is not during treatment.
Six, model case:
Case 1: Hu, man, 5 years old. In medical the last week, left side arm and back occur more and more many red specklees, slight gargalesthesia successively, and under the environment of heat, gargalesthesia can increase, and three disappear gradually after surrounding.Period used tissue amine and corticoid Drug therapy, but Relapse rate after drug withdrawal. After 2 courses for the treatment of of medicament taking prepared by the Chinese medicine composition of the present invention, conscious gargalesthesia substantially alleviates, and speckle major part disappears; Continue to take 3 courses for the treatment of, transference cure, cure.
Case 2: Zhang, female, 8 years old. Stating time medical: one piece bigger cerise speckle occur from the beginning of back, in, two weeks subsequently, trunk, extremity occur circular patches successively, there is a squama in small, broken bits on surface, and has the different gargalesthesia of weight. Taking 3 courses for the treatment of of medicament prepared by the Chinese medicine composition of the present invention, skin lesion significantly alleviates, and speckle color is thin out; Continue after taking 3 courses for the treatment of, each transference cure, cure.
Claims (2)
1. treat roseolous Chinese medicine composition for one kind, it is characterized in that: its raw material of Chinese medicine and weight be: Flos Lonicerae 10-30 part, Radix Arnebiae (Radix Lithospermi) 10-20 part, Fructus Kochiae 5-15 part, Fructus Atriplicis Sibiricae 10-20 part, Flos Chrysanthemi 10-20 part, Radix Ophiopogonis 5-15 part, Radix Isatidis 10-20 part, Folium Isatidis 10-20 part, Periostracum Cicadae 5-15 part, Herba Ecliptae 10-20 part, Radix Salviae Miltiorrhizae 10-20 part, Radix Et Rhizoma Rhei 10-20 part, Fructus Forsythiae 5-15 part, Hibisci Mutabilis 10-20 part, Radix Scrophulariae 10-20 part, Rhizoma Cimicifugae 5-15 part, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 10-20 part, Rhizoma Chuanxiong 10-20 part, Stigma Croci 5-15 part, Herba Vernoniae Patulae 10-20 part, Fructus Gardeniae 10-20 part, ramie leaf 10-20 part, Radix Glycyrrhizae 5-15 part.
2. one according to claim 1 treats roseolous Chinese medicine composition, it is characterised in that: its raw material of Chinese medicine and weight be: Flos Lonicerae 20 parts, Radix Arnebiae (Radix Lithospermi) 15 parts, the Fructus Kochiae 10 parts, Fructus Atriplicis Sibiricae 15 parts, Flos Chrysanthemi 15 parts, Radix Ophiopogonis 10 parts, Radix Isatidis 15 parts, Folium Isatidis 15 parts, Periostracum Cicadae 10 parts, Herba Ecliptae 15 parts, Radix Salviae Miltiorrhizae 15 parts, Radix Et Rhizoma Rhei 15 parts, Fructus Forsythiae 10 parts, Hibisci Mutabilis 15 parts, Radix Scrophulariae 15 parts, Rhizoma Cimicifugae 10 parts, Herba Lysimachiae Clethroids (Radix Seu Herba Lysimachiae Clethroidis) 15 parts, Rhizoma Chuanxiong 15 parts, Stigma Croci 10 parts, Herba Vernoniae Patulae 15 parts, Fructus Gardeniae 15 parts, ramie leaf 15 parts, 10 parts of Radix Glycyrrhizae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610100666.3A CN105641404A (en) | 2016-02-24 | 2016-02-24 | Traditional Chinese medicine composition for treating roseola |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610100666.3A CN105641404A (en) | 2016-02-24 | 2016-02-24 | Traditional Chinese medicine composition for treating roseola |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105641404A true CN105641404A (en) | 2016-06-08 |
Family
ID=56488687
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610100666.3A Pending CN105641404A (en) | 2016-02-24 | 2016-02-24 | Traditional Chinese medicine composition for treating roseola |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105641404A (en) |
-
2016
- 2016-02-24 CN CN201610100666.3A patent/CN105641404A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463528B (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN103479929B (en) | Traditional Chinese medicine composition for treating pruritus | |
| CN105616759A (en) | Traditional Chinese medicine composition for treating urticaria | |
| CN103720996A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
| CN104013910A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN105267674A (en) | Traditional Chinese medicine composition for treating acute mastitis | |
| CN104758726A (en) | Traditional Chinese medicine composition for treating urinary tract infection | |
| CN104606514A (en) | Traditional Chinese medicine composition for treating kidney deficiency type tinnitus | |
| CN103463397B (en) | Traditional Chinese medicine composition for treating deficiency of kidney-yin | |
| CN106075265A (en) | The Chinese medicine composition for the treatment of viral influenza | |
| CN105287949A (en) | Traditional Chinese medicinal composition for treating dysmenorrhea | |
| CN105148235A (en) | Traditional Chinese medicine combination treating postpartum hemorrhage | |
| CN105079515A (en) | Traditional Chinese medicine composition for treating post-traumatic headache | |
| CN104606471A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN103211998B (en) | Traditional Chinese medicine composition for treatment of yin deficiency and yang excess | |
| CN104001100A (en) | Traditional Chinese medicine composition for treating PICC (Peripherally Inserted Central Catheter) phlebothrombosis and preparation method of traditional Chinese medicine composition | |
| CN104013828A (en) | Traditional Chinese medicine composition for treating head wind caused by liver-yang hyperactivity | |
| CN105641404A (en) | Traditional Chinese medicine composition for treating roseola | |
| CN103223113B (en) | Traditional Chinese medicine composition for treating functional uterine bleeding | |
| CN105617288A (en) | Traditional Chinese medicine composition for treating anaphylactoid purpura | |
| CN105770655A (en) | Traditional Chinese medicine composition for treating scroti eczema | |
| CN105079327A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN104758784A (en) | Traditional Chinese medicine composition for treating chronic gastritis | |
| CN104161990A (en) | Traditional Chinese medicine composition for treating cardiopalmus | |
| CN101972335A (en) | Chinese medicinal preparation for treating molluscum contagiosum |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160608 |